BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24247554)

  • 1. Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial.
    Poole J; Mavromatis K; Binongo JN; Khan A; Li Q; Khayata M; Rocco E; Topel M; Zhang X; Brown C; Corriere MA; Murrow J; Sher S; Clement S; Ashraf K; Rashed A; Kabbany T; Neuman R; Morris A; Ali A; Hayek S; Oshinski J; Yoon YS; Waller EK; Quyyumi AA
    JAMA; 2013 Dec; 310(24):2631-9. PubMed ID: 24247554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial.
    McDermott MM; Ferrucci L; Tian L; Guralnik JM; Lloyd-Jones D; Kibbe MR; Polonsky TS; Domanchuk K; Stein JH; Zhao L; Taylor D; Skelly C; Pearce W; Perlman H; McCarthy W; Li L; Gao Y; Sufit R; Bloomfield CL; Criqui MH
    JAMA; 2017 Dec; 318(21):2089-2098. PubMed ID: 29141087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Differences in the Effect of Granulocyte Macrophage Colony-Stimulating Factor on Improved Walking Distance in Peripheral Artery Disease: The PROPEL Randomized Clinical Trial.
    McDermott MM; Polonsky TS; Guralnik JM; Ferrucci L; Tian L; Zhao L; Stein J; Domanchuk K; Criqui MH; Taylor DA; Li L; Kibbe MR
    J Am Heart Assoc; 2019 Jan; 8(2):e011001. PubMed ID: 30661439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.
    Mehta A; Mavromatis K; Ko YA; Rogers SC; Dhindsa DS; Goodwin C; Patel R; Martini MA; Prasad M; Mokhtari A; Hesaroieh IG; Frohwein SC; Kutner MH; Harzand A; Wells BJ; Duwayri Y; Alabi O; Rajani RR; Brewster LP; Waller EK; Quyyumi AA
    Contemp Clin Trials; 2020 Apr; 91():105975. PubMed ID: 32145440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease.
    Subramaniyam V; Waller EK; Murrow JR; Manatunga A; Lonial S; Kasirajan K; Sutcliffe D; Harris W; Taylor WR; Alexander RW; Quyyumi AA
    Am Heart J; 2009 Jul; 158(1):53-60.e1. PubMed ID: 19540392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial. Journal of the American Medical Association 2013; 309: 453-460.
    Kurklinsky AK; Levy M
    Vasc Med; 2013 Aug; 18(4):234-6. PubMed ID: 23867841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial.
    McDermott MM; Liu K; Guralnik JM; Criqui MH; Spring B; Tian L; Domanchuk K; Ferrucci L; Lloyd-Jones D; Kibbe M; Tao H; Zhao L; Liao Y; Rejeski WJ
    JAMA; 2013 Jul; 310(1):57-65. PubMed ID: 23821089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: the PROPEL Study.
    Domanchuk K; Ferrucci L; Guralnik JM; Criqui MH; Tian L; Liu K; Losordo D; Stein J; Green D; Kibbe M; Zhao L; Annex B; Perlman H; Lloyd-Jones D; Pearce W; Taylor D; McDermott MM
    Contemp Clin Trials; 2013 Nov; 36(2):502-9. PubMed ID: 24080099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
    Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA
    JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial.
    McDermott MM; Ades P; Guralnik JM; Dyer A; Ferrucci L; Liu K; Nelson M; Lloyd-Jones D; Van Horn L; Garside D; Kibbe M; Domanchuk K; Stein JH; Liao Y; Tao H; Green D; Pearce WH; Schneider JR; McPherson D; Laing ST; McCarthy WJ; Shroff A; Criqui MH
    JAMA; 2009 Jan; 301(2):165-74. PubMed ID: 19141764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Cell Therapy on Exercise Performance and Limb Perfusion in Peripheral Artery Disease: The CCTRN PACE Trial (Patients With Intermittent Claudication Injected With ALDH Bright Cells).
    Perin EC; Murphy MP; March KL; Bolli R; Loughran J; Yang PC; Leeper NJ; Dalman RL; Alexander J; Henry TD; Traverse JH; Pepine CJ; Anderson RD; Berceli S; Willerson JT; Muthupillai R; Gahremanpour A; Raveendran G; Velasquez O; Hare JM; Hernandez Schulman I; Kasi VS; Hiatt WR; Ambale-Venkatesh B; Lima JA; Taylor DA; Resende M; Gee AP; Durett AG; Bloom J; Richman S; G'Sell P; Williams S; Khan F; Gyang Ross E; Santoso MR; Goldman J; Leach D; Handberg E; Cheong B; Piece N; DiFede D; Bruhn-Ding B; Caldwell E; Bettencourt J; Lai D; Piller L; Simpson L; Cohen M; Sayre SL; Vojvodic RW; Moyé L; Ebert RF; Simari RD; Hirsch AT;
    Circulation; 2017 Apr; 135(15):1417-1428. PubMed ID: 28209728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Telmisartan on Walking Performance in Patients With Lower Extremity Peripheral Artery Disease: The TELEX Randomized Clinical Trial.
    McDermott MM; Bazzano L; Peterson CA; Sufit R; Ferrucci L; Domanchuk K; Zhao L; Polonsky TS; Zhang D; Lloyd-Jones D; Leeuwenburgh C; Guralnik JM; Kibbe MR; Kosmac K; Criqui MH; Tian L
    JAMA; 2022 Oct; 328(13):1315-1325. PubMed ID: 36194220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials.
    Regensteiner JG; Ware JE; McCarthy WJ; Zhang P; Forbes WP; Heckman J; Hiatt WR
    J Am Geriatr Soc; 2002 Dec; 50(12):1939-46. PubMed ID: 12473004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.
    Fakhry F; Spronk S; van der Laan L; Wever JJ; Teijink JA; Hoffmann WH; Smits TM; van Brussel JP; Stultiens GN; Derom A; den Hoed PT; Ho GH; van Dijk LC; Verhofstad N; Orsini M; van Petersen A; Woltman K; Hulst I; van Sambeek MR; Rizopoulos D; Rouwet EV; Hunink MG
    JAMA; 2015 Nov; 314(18):1936-44. PubMed ID: 26547465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care on Walking in Adults With Peripheral Artery Disease: The MOSAIC Randomized Clinical Trial.
    Bearne LM; Volkmer B; Peacock J; Sekhon M; Fisher G; Galea Holmes MN; Douiri A; Amirova A; Farran D; Quirke-McFarlane S; Modarai B; Sackley C; Weinman J; Bieles J;
    JAMA; 2022 Apr; 327(14):1344-1355. PubMed ID: 35412564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of ankle-foot orthoses on walking ability in peripheral artery disease.
    Mays RJ; Mays AA; Mizner RL
    Vasc Med; 2019 Aug; 24(4):324-331. PubMed ID: 30924412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of High-pressure, Intermittent Pneumatic Compression for the Treatment of Peripheral Arterial Disease and Critical Limb Ischemia in Patients Without a Surgical Option.
    Alvarez OM; Wendelken ME; Markowitz L; Comfort C
    Wounds; 2015 Nov; 27(11):293-301. PubMed ID: 26574751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.
    van Royen N; Schirmer SH; Atasever B; Behrens CY; Ubbink D; Buschmann EE; Voskuil M; Bot P; Hoefer I; Schlingemann RO; Biemond BJ; Tijssen JG; Bode C; Schaper W; Oskam J; Legemate DA; Piek JJ; Buschmann I
    Circulation; 2005 Aug; 112(7):1040-6. PubMed ID: 16087795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-based walking exercise for peripheral artery disease: An exploratory pilot study.
    Mays RJ; Hiatt WR; Casserly IP; Rogers RK; Main DS; Kohrt WM; Ho PM; Regensteiner JG
    Vasc Med; 2015 Aug; 20(4):339-47. PubMed ID: 25755148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.